Gland Pharma Limited (BOM:543245)
3,331.35
+40.30 (1.22%)
At close: Nov 20, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 549.65 billion as of November 20, 2026. Its market cap has increased by 88.50% in one year.
Market Cap
549.65B
Enterprise Value
517.75B
Revenue
70.72B
Global Rank
n/a
Country Rank
n/a
PE Ratio
44.49
ChartMarket Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 549.65B, an increase of 85.01%. That is a compound annual growth rate of 10.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 549.65B | 93.74% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.15T |
| Mankind Pharma | 1.09T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 736.17B |
| Alkem Laboratories | 615.16B |
| Gland Pharma | 543.57B |
| Ipca Laboratories | 473.16B |
| Emcure Pharmaceuticals | 445.75B |